Below is a comprehensive archive of press releases from MSF-USA. Use the options in the boxes below to filter results based on your preferences.

Country/Region

June 09, 2016

UN governments adopted a Political Declaration on Ending AIDS during the UN’s High-Level Meeting on Ending AIDS in New York on June 8, 2016, in which governments have committed to reaching 30 million people with HIV treatment by 2020.

June 02, 2016

India must resist pressure from US lawmakers and pharmaceutical industry groups to block access to key medicines for millions of people worldwide

May 10, 2016

Gilead Sciences has been seeking patents in India for the hepatitis C drug sofosbuvir. The patent applications have been challenged by groups of people living with hepatitis C and HIV through "pre-grant oppositions." The patent just granted by India’s patent office was initially rejected in January 2015, just before President Obama’s visit to India, which was seen as vexing the US. Gilead appealed the rejection and the patent has now been granted.

April 21, 2016

In advance of the next round of the Regional Comprehensive Economic Partnership (RCEP) negotiations starting in Perth, Australia, this Sunday, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) is warning that current proposals in this trade agreement could severely restrict access to affordable medicines for millions of people around the world. Text from a leaked chapter on intellectual property shows that Japan and South Korea have made proposals that go beyond what international trade rules require, undermining access to affordable generic medicines and making it harder for patients and treatment providers like MSF to access affordable, lifesaving medicines.

March 29, 2016

MSF urges Indian Prime Minister not to cave into pressure from EU to accept trade deal that could prevent millions of people from accessing lifesaving medicines

March 11, 2016

New York/New Delhi—Doctors Without Borders/Médecins Sans Frontières (MSF) has filed a "patent opposition" in India to block US pharmaceutical company Pfizer from patenting a pneumococcal conjugate vaccine, and ensure affordable access to this critical vaccine (PCV13). This is the first time a vaccine (biosimilar) patent has been challenged in India by a medical organization and, if successful, will make affordable versions of this lifesaving vaccine available to developing countries and humanitarian organizations.

February 26, 2016

New York/New Delhi—In proceedings that could have major implications for millions of people waiting for affordable access to a lifesaving hepatitis C drug, the Indian Patent Office this week began hearings to determine whether US pharmaceutical company Gilead Sciences deserves a patent for sofosbuvir, a hepatitis C drug for which the company currently charges $1,000 per pill in the US.

February 10, 2016

Delhi/New York—A patient living with HIV in India has filed an application to try to block ViiV Healthcare from being granted patents on two new critical HIV drugs, the medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) announced today.

September 28, 2015

NEW YORK—As US president Barack Obama and Indian prime minister Narendra Modi meet in New York today, Doctors Without Borders/Médecins Sans Frontières (MSF) warned that US pressure on India to change its intellectual property policies could result in millions of people around the world losing their lifeline of affordable medicines.

June 12, 2015

New Delhi/GenevaThe international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) today launched a global campaign urging Indian Prime Minister Narendra Modi to stand strong in the face of intensifying multinational pressure to change India’s laws and policies that would severely restrict production of affordable medicines, upon which millions of people around the world depend.

Pages